Risk-stratified surveillance in dermatofibrosarcoma protuberans: Less is more

Rebecca A Gladdy^{1

2}, Jay S Wunder^{2

3

4}

Affiliations

¹ Division of General Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
² Sarcoma Site Group, Princess Margaret Cancer Centre and Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
³ Division of Orthopedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁴ University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada.

Free article

Editorial

Rebecca A Gladdy et al. Cancer. 2019.

Free article

. 2019 Mar 1;125(5):670-672.

doi: 10.1002/cncr.31922. Epub 2019 Jan 15.

Rebecca A Gladdy^{1

2}, Jay S Wunder^{2

3

4}

¹ Division of General Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
² Sarcoma Site Group, Princess Margaret Cancer Centre and Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
³ Division of Orthopedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
⁴ University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada.

No abstract available

Comment on

Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
Huis In 't Veld EA, van Coevorden F, Grünhagen DJ, Smith MJ, van Akkooi ACJ, Wouters MWJM, Hayes AJ, Verhoef C, Strauss DC, van Houdt WJ. Huis In 't Veld EA, et al. Cancer. 2019 Mar 1;125(5):735-741. doi: 10.1002/cncr.31924. Epub 2019 Jan 15. Cancer. 2019. PMID: 30644528